about
Is there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?In vitro evolution of allergy vaccine candidates, with maintained structure, but reduced B cell and T cell activation capacityTargeting the extracellular membrane-proximal domain of membrane-bound IgE by passive immunization blocks IgE synthesis in vivo.Developments in laboratory diagnostics for isocyanate asthma.Immunomodulation: the future cure for allergic diseases.Inhibition of IgE Activity to Bind its High Affinity Receptor (FcεRIα) by Mouse Anti-IgE Cε3∼4 Monoclonal Antibody (QME5).Apoptosis, airway inflammation and anti-asthma therapy: from immunobiology to clinical application.Current concepts of IgE regulation and impact of genetic determinants.Drug Repurposing to treat Asthma and Allergic Disorders: Progress and Prospects.Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.Omalizumab may decrease IgE synthesis by targeting membrane IgE+ human B cells.Analysis of patents on anti-allergic therapies issued in China from 1988 to 2008.Effects of adding omalizumab, an anti-immunoglobulin E antibody, on airway wall thickening in asthma.
P2860
Q26998459-48110A4C-81C9-4126-B7E2-C4E06B17EDC9Q34023674-977B9E3D-46C6-44C1-8D8E-5BE4C92B8E25Q34222417-3425636B-661C-4769-873A-C2B7A9A4F093Q35090007-A396D3EB-871D-468C-9E4B-944B691945C4Q36693947-D2E656CA-23C4-4272-BC36-E243A4ABEE0CQ36735617-C5316A91-2025-4CF3-9D03-0FE6C5C0FEA0Q37052175-92D79C93-010A-495F-889F-F7BD2B519BDAQ38036378-60D59710-DC4E-4FEE-90C9-64C9B20DCA6EQ39150081-1883A5F9-1708-44ED-BDE0-898A8646CB84Q40889826-374F4662-E91A-4D81-9455-691A8FC6A9C5Q42771088-AF2EBD35-D393-4EE9-8C46-077DA2B76840Q43061739-27B1D015-5158-41BF-A0DE-345E61DB27E2Q48498634-D1764865-3618-41EF-9DE7-0B922475DCEE
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular and cellular targets of anti-IgE antibodies.
@ast
Molecular and cellular targets of anti-IgE antibodies.
@en
type
label
Molecular and cellular targets of anti-IgE antibodies.
@ast
Molecular and cellular targets of anti-IgE antibodies.
@en
prefLabel
Molecular and cellular targets of anti-IgE antibodies.
@ast
Molecular and cellular targets of anti-IgE antibodies.
@en
P2093
P2860
P1433
P1476
Molecular and cellular targets of anti-IgE antibodies.
@en
P2093
P2860
P304
P356
10.1111/J.1398-9995.2005.00832.X
P577
2005-08-01T00:00:00Z